QuantHealth
AI-driven clinical trial simulation that models patient responses before trials enroll.
Healthcare
📍 Tel Aviv, Israel
Current Valuation
Private
PRIVATE
QuantHealth is a Tel Aviv, Israel-based provider of an AI-driven clinical trial simulation platform for pharma and biotech, using predictive modeling to test and optimize trials before patients enroll or capital is committed. Led by CEO Orr Inbar, it has simulated 600+ clinical trials across 30 indications at up to 90% predictive accuracy and partners with 12 of the world's top 20 pharmaceutical companies. In August 2026 it raised a $45M Series B led by Qumra Capital, with Pitango HealthTech, Sanofi Ventures, and Artofin, to accelerate simulation-first clinical development.
Company Profile
Growth
Partners with 12 of the top 20 pharma; 600+ trials simulated at up to 90% accuracy
Last Round
Series B — $45M (Aug 2026) · Lead: Qumra Capital
Fundraising Status
Series B · $45M · this month
privateTotal raised $45M1 disclosed rounds
Funding History
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series B | $45M | Aug 2026 | Qumra Capital | — |
Founders & Key People
Orr Inbar
Investors
Qumra Capital · Pitango HealthTech · Sanofi Ventures · Artofin
Products
- AI clinical trial simulation platform
- Simulation-first / in-silico clinical development
Competitors
Unlearn.AI · Formation Bio · Median Technologies · Aignostics
HealthcareAIClinical TrialsDrug DevelopmentSimulation
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.